Cargando…

Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti-TNF protocols

The impact of diacerein, an effective cartilage targeted therapy that is used in patients with osteoarthritis, on the development and progression of chronic inflammatory arthritis was evaluated in a tumor necrosis factor (TNF) transgenic mouse model (Tg197). The response to diacerein at 2, 20, or 60...

Descripción completa

Detalles Bibliográficos
Autores principales:	Douni, Eleni, Sfikakis, Petros P, Haralambous, Sylva, Fernandes, Peter, Kollias, George
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC400419/ https://www.ncbi.nlm.nih.gov/pubmed/14979939 http://dx.doi.org/10.1186/ar1028

Ejemplares similares

A Critical Role of the p75 Tumor Necrosis Factor Receptor (p75TNF-R) in Organ Inflammation Independent of TNF, Lymphotoxin α, or the p55TNF-R
por: Douni, Eleni, et al.
Publicado: (1998)

Effect of phospholipase A(2 )inhibitory peptide on inflammatory arthritis in a TNF transgenic mouse model: a time-course ultrastructural study
por: Thwin, Maung-Maung, et al.
Publicado: (2004)

TNFα depleting therapy improves fertility and animal welfare in TNFα-driven transgenic models of polyarthritis when administered in their routine breeding
por: Naylor, Amy J., et al.
Publicado: (2017)

Comorbid TNF-mediated heart valve disease and chronic polyarthritis share common mesenchymal cell-mediated aetiopathogenesis
por: Ntari, Lydia, et al.
Publicado: (2018)

An integrative transcriptome analysis framework for drug efficacy and similarity reveals drug-specific signatures of anti-TNF treatment in a mouse model of inflammatory polyarthritis
por: Karagianni, Niki, et al.
Publicado: (2019)

The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era
por: Evangelatos, Gerasimos, et al.
Publicado: (2022)

In Silico Discovery of Plant-Origin Natural Product Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
por: Melagraki, Georgia, et al.
Publicado: (2018)

Osteoprotegerin protects from generalized bone loss in TNF-transgenic mice
por: Hayer, S, et al.
Publicado: (2003)

Effect of osteoprotegerin and pamidronate treatment in transgenic mice overexpressing human TNF
por: Redlich, K, et al.
Publicado: (2001)

Methotrexate Enhances Apoptosis of Transmembrane TNF-Expressing Cells Treated With Anti-TNF Agents
por: Wang, Qiaolei, et al.
Publicado: (2020)

Cheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
por: Melagraki, Georgia, et al.
Publicado: (2017)

Adenoviral-based overexpression of TIMP-1 reduces tissue damage in the joints TNF-transgenic mice
por: Schett, G, et al.
Publicado: (2001)

Membrane-Bound TNF Induces Protective Immune Responses to M. bovis BCG Infection: Regulation of memTNF and TNF Receptors Comparing Two memTNF Molecules
por: Olleros, Maria L., et al.
Publicado: (2012)

Can clinical factors at presentation be used to predict outcome of treatment with methotrexate in patients with early inflammatory polyarthritis?
por: Hider, S L, et al.
Publicado: (2009)

Single-cell multimodal analysis identifies common regulatory programs in synovial fibroblasts of rheumatoid arthritis patients and modeled TNF-driven arthritis
por: Armaka, Marietta, et al.
Publicado: (2022)

An Anti-hTNF-α Variable New Antigen Receptor Format Demonstrates Superior in vivo Preclinical Efficacy to Humira® in a Transgenic Mouse Autoimmune Polyarthritis Disease Model
por: Ubah, Obinna C., et al.
Publicado: (2019)

Tumor Necrosis Factor (TNF) Receptor Shedding Controls Thresholds of Innate Immune Activation That Balance Opposing TNF Functions in Infectious and Inflammatory Diseases
por: Xanthoulea, Sofia, et al.
Publicado: (2004)

Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment
por: Li, Xuefei, et al.
Publicado: (2023)

Uncoupling the Proinflammatory from the Immunosuppressive Properties of Tumor Necrosis Factor (Tnf) at the P55 TNF Receptor Level: Implications for Pathogenesis and Therapy of Autoimmune Demyelination
por: Kassiotis, George, et al.
Publicado: (2001)

Adenoviral-based overexpression of TIMP-1 reduces tissue damage in the joints of TNF-alpha transgenic mice
por: Schett, G, et al.
Publicado: (2001)

Overexpression of TNF causes bilateral sacroiliitis
por: Redlich, K, et al.
Publicado: (2004)

Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab
por: Dénarié, Delphine, et al.
Publicado: (2017)

Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment
por: Ntari, Lydia, et al.
Publicado: (2021)

Clopidogrel-Associated Migratory Inflammatory Polyarthritis
por: Ayesha, Bibi, et al.
Publicado: (2019)

Copper Deficiency in the Lungs of TNF-α Transgenic Mice
por: Liu, Liu, et al.
Publicado: (2016)

Risk factors for oral methotrexate failure in patients with inflammatory polyarthritis: results from a UK prospective cohort study
por: Bluett, James, et al.
Publicado: (2018)

Functional analysis of an arthritogenic synovial fibroblast
por: Aidinis, Vassilis, et al.
Publicado: (2003)

A monocyte‐TNF‐endothelial activation axis in sickle transgenic mice: Therapeutic benefit from TNF blockade
por: Solovey, Anna, et al.
Publicado: (2017)

Treatment with TNF‐α inhibitors versus methotrexate and the association with dementia and Alzheimer's disease
por: Kern, David M., et al.
Publicado: (2021)

Blocking TNFα attenuates progressive cartilage matrix degradation in inflammatory arthritis
por: Park, Jinsung, et al.
Publicado: (2021)

Attenuation of TNF-driven murine ileitis by intestinal expression of the viral immunomodulator CrmD
por: Viejo-Borbolla, Abel, et al.
Publicado: (2010)

Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases
por: Armaka, Maria, et al.
Publicado: (2008)

Reposition of the anti-inflammatory drug diacerein in an in-vivo colorectal cancer model
por: Abdel-Latif, Raghda T., et al.
Publicado: (2022)

An extensive phenotypic characterization of the hTNFα transgenic mice
por: Hayward, Michael D, et al.
Publicado: (2007)

Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease
por: Haberman, Rebecca H, et al.
Publicado: (2022)

Ion-pair compounds of diacerein for enhancing skin permeability in vitro: the compatibility–permeability relationship of counter ion and diacerein
por: Liang, Yan, et al.
Publicado: (2022)

TNF overexpression and dexamethasone treatment impair chondrogenesis and bone growth in an additive manner
por: Zhao, Yunhan, et al.
Publicado: (2022)

Osteoclasts are essential for TNF-mediated joint destruction
por: Redlich, KR, et al.
Publicado: (2002)

TNFα blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats
por: Milia, Anna Franca, et al.
Publicado: (2009)

Methotrexate as combination partner of TNF inhibitors and tocilizumab. What is reasonable from an immunological viewpoint?
por: Witte, Torsten
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_skcvb30f3c26l7lf327c7bm6tr